Mesa Laboratories, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of directors: J. Sullivan

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: John J. Sullivan, Ph.D.”): 4,690,793 for, 195,707 withheld, per its Form 8-K filed August 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 2,616,761 for, 321 withheld, 305 abstained.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of directors: G. Owens

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Gary M. Owens”): 4,717,660 for, 168,840 withheld, per its Form 8-K filed August 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company's proxy statement for the Annual Meeting, are as follows: Proposal 1 – Election of directors Each of John J. Sullivan, Gary M. Owens, Jenny S. Alltoft, Shannon M. Hall, Shiraz S. Lad…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 2,616,656 for, 731 withheld.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of directors: J. Alltoft

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Jennifer S. Alltoft”): 4,775,822 for, 110,678 withheld, per its Form 8-K filed August 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company's proxy statement for the Annual Meeting, are as follows: Proposal 1 – Election of directors Each of John J. Sullivan, Gary M. Owens, Jenny S. Alltoft, Shannon M. Hall, Shiraz S. Lad…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 2,609,460 for, 1,857 withheld, 6,069 abstained.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of directors: M. Capone

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Mark C. Capone”): 4,845,315 for, 41,185 withheld, per its Form 8-K filed August 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company's proxy statement for the Annual Meeting, are as follows: Proposal 1 – Election of directors Each of John J. Sullivan, Gary M. Owens, Jenny S. Alltoft, Shannon M. Hall, Shiraz S. Lad…”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 2,617,387 for.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of directors: T. Tripeny

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: R. Tony Tripeny”): 4,844,064 for, 42,436 withheld, per its Form 8-K filed August 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company's proxy statement for the Annual Meeting, are as follows: Proposal 1 – Election of directors Each of John J. Sullivan, Gary M. Owens, Jenny S. Alltoft, Shannon M. Hall, Shiraz S. Lad…”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 2,617,387 for.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of directors: S. Hall

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Shannon M. Hall”): 4,767,236 for, 119,264 withheld, per its Form 8-K filed August 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company's proxy statement for the Annual Meeting, are as follows: Proposal 1 – Election of directors Each of John J. Sullivan, Gary M. Owens, Jenny S. Alltoft, Shannon M. Hall, Shiraz S. Lad…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 2,609,460 for, 1,857 withheld, 6,069 abstained.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of directors: S. Ladiwala

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Shiraz S. Ladiwala”): 4,788,493 for, 98,007 withheld, per its Form 8-K filed August 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company's proxy statement for the Annual Meeting, are as follows: Proposal 1 – Election of directors Each of John J. Sullivan, Gary M. Owens, Jenny S. Alltoft, Shannon M. Hall, Shiraz S. Lad…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 2,609,460 for, 1,857 withheld, 6,069 abstained.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: To approve the Amendment to the Mesa Laboratories, Inc. 2021 Equity Incentive Plan.

Mesa Laboratories, Inc.’s own tally for this item (“4. Approval of an amendment to the Mesa Laboratories, Inc”): 4,601,685 for, 247,476 against — passed, per its Form 8-K filed August 25, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 – Approval of an amendment to the Mesa Laboratories, Inc. 2021 Equity Incentive Plan The amendment to the Company's 2021 Equity Incentive Plan was approved:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 64 asset managers below reported 2,589,465 for, 20,403 against, 2,800 abstained.

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

Description as filed by funds: To approve, on an advisory basis, the Company's named executive officer compensation.

Mesa Laboratories, Inc.’s own tally for this item (“3. Approval on a non-binding basis of the compensation of the Company's named executive officers The compensation of the Company's named executive officers, as disclosed in the proxy statement”): 4,476,544 for, 275,297 against — passed, per its Form 8-K filed August 25, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Approval on a non-binding basis of the compensation of the Company's named executive officers The compensation of the Company's named executive officers, as disclosed in the proxy statement, was approved on a non-binding advisory basis:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 65 managers: 2,561,257 for, 56,129 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 188 managers: 2,278,210 for, 95,281 against, 102,198 abstained, 223 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending March 31, 2026.

Mesa Laboratories, Inc.’s own tally for this item (“2. Ratification of the selection by our Audit Committee of Baker Tilly US, LLP to serve as the Company ' s independent registered public accounting firm for the fiscal year ending March 31, 2026 The appointment of Baker ”): 5,200,789 for, 1,732 against — passed, per its Form 8-K filed August 25, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Subsequent to the election of the board members, the Board of Directors appointed members to its committees as follows: Proposal 2 – Ratification of the selection by our Audit Committee of Baker Tilly US, LLP to serve as the Company ' s independent registered public accounting firm for the fiscal y…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 2,617,387 for.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.